4
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Why are people with intellectual disabilities clinically vulnerable to COVID-19?

      discussion
      a , a
      The Lancet. Public Health
      The Author(s). Published by Elsevier Ltd.

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In The Lancet Public Health, Maarten Cuypers and colleagues 1 add to the growing literature showing that people with intellectual disabilities were more likely to die from COVID-19 during the first 2 years of the pandemic—in this paper around five-times more likely. Putting these figures into context, around 600 more people with intellectual disabilities died in the Netherlands than would be expected if they had the mortality rates of others in the population. Cuypers and colleagues also showed that this mortality gap existed before the pandemic, and that non-COVID causes of death were elevated for people with intellectual disabilities during the pandemic. Other sources of data show that the adverse impact of COVID-19 for people with intellectual disabilities went beyond mortality risk. For instance, qualitative research highlights the isolation, loneliness, and lost sense of self-worth experienced by people with intellectual disabilities during the COVID-19 pandemic.2, 3 Family members and caregivers were also put under immense strain. 4 A key question is why the impact of COVID-19 was greater for people with intellectual disabilities? More fundamentally, why was this group clinically vulnerable? First, we must consider the nature and cause of vulnerability. Some people with intellectual disabilities have a biological vulnerability to COVID-19. For instance, immune response dysfunction in people with Down syndrome is likely to contribute to their elevated risk of dying from COVID-19—in a study over a 30-times increased risk of death was found. 5 Other individuals with intellectual disabilities might be at elevated risk of death from COVID-19 because of a high prevalence of other risk factors, such as obesity or diabetes. 6 However, we must also recognise the discriminatory and exclusionary social structures that create clinical vulnerability in people with disabilities, particularly people with intellectual disabilities. Inaccessible health facilities and health information, removal of social care, a lack of protective measures in care homes, poorly trained health staff, and delayed vaccine prioritisation are all failings that made people with intellectual disabilities clinically vulnerable to COVID-19. People with intellectual disabilities were abandoned and forgotten in government responses to the pandemic across the world, particularly in the early stages.2, 4 They were made clinically vulnerable, in part, by neglect. Sadly, this information is not new. For many years, there has been substantial evidence on health inequalities of people with intellectual disabilities because of structural, societal, and institutional failings, but governments have not adequately responded, entrenching clinical vulnerability. 7 These failings include the social inequalities for people with disabilities, such as poor access to health care, education, and employment, poverty, and an increased risk of violence and abuse. 8 These social inequalities further contribute to the clinical vulnerability of people with intellectual disabilities to health issues (including mental health problems). We should not place the burden of clinical vulnerability to COVID-19 (and wider morbidity and mortality) on individual people with intellectual disabilities, but on the failings of our societies, policies, and services. As we move forward, there is hope and potential power in data, such as the study by Cuypers and colleagues, 1 to highlight and address health risks. Evidence showing that people with intellectual disabilities were more likely to die from COVID-19 allowed them to be prioritised for vaccination in many countries, including in the UK. 9 As another example, the 2013 UK Confidential Inquiry showed that people with intellectual disabilities were dying 13–20 years earlier than their peers without disabilities, often because of health systems failure. 10 Consequently, the UK National Health Service introduced a range of services to close this gap, including mandatory training of health-care workers about intellectual disability, establishment of a learning disability register, invitation to routine health check-ups, and routine monitoring of the health gaps through the Learning Disability Mortality Review.11, 12 Although there is huge progress still to be made, we should take inspiration from these concrete examples of how evidence can be transformative. We need to put people with disabilities at the centre of health-care planning and delivery, so that inclusion in health care is not considered nice to have, but is entrenched as a priority and a right. We must not assume that these issues are too expensive or complex to address. There is a growing range of good practice, showing how we can create inclusive health systems, and how they are likely to be cost saving and work better for all.13, 14 In the words of the recently deceased Disability Rights activist Judy Heumann, “most things are possible when you assume problems can be solved”. 15 We declare no competing interests.

          Related collections

          Most cited references9

          • Record: found
          • Abstract: found
          • Article: not found

          The Confidential Inquiry into premature deaths of people with intellectual disabilities in the UK: a population-based study.

          The Confidential Inquiry into premature deaths of people with intellectual disabilities in England was commissioned to provide evidence about contributory factors to avoidable and premature deaths in this population.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform

            Objective To assess the association between learning disability and risk of hospital admission and death from covid-19 in England among adults and children. Design Population based cohort study on behalf of NHS England using the OpenSAFELY platform. Setting Patient level data were obtained for more than 17 million people registered with a general practice in England that uses TPP software. Electronic health records were linked with death data from the Office for National Statistics and hospital admission data from NHS Secondary Uses Service. Participants Adults (aged 16-105 years) and children (<16 years) from two cohorts: wave 1 (registered with a TPP practice as of 1 March 2020 and followed until 31 August 2020); and wave 2 (registered 1 September 2020 and followed until 8 February 2021). The main exposure group consisted of people on a general practice learning disability register; a subgroup was defined as those having profound or severe learning disability. People with Down’s syndrome and cerebral palsy were identified (whether or not they were on the learning disability register). Main outcome measure Covid-19 related hospital admission and covid-19 related death. Non-covid-19 deaths were also explored. Results For wave 1, 14 312 023 adults aged ≥16 years were included, and 90 307 (0.63%) were on the learning disability register. Among adults on the register, 538 (0.6%) had a covid-19 related hospital admission; there were 222 (0.25%) covid-19 related deaths and 602 (0.7%) non-covid deaths. Among adults not on the register, 29 781 (0.2%) had a covid-19 related hospital admission; there were 13 737 (0.1%) covid-19 related deaths and 69 837 (0.5%) non-covid deaths. Wave 1 hazard ratios for adults on the learning disability register (adjusted for age, sex, ethnicity, and geographical location) were 5.3 (95% confidence interval 4.9 to 5.8) for covid-19 related hospital admission and 8.2 (7.2 to 9.4) for covid-19 related death. Wave 2 produced similar estimates. Associations were stronger among those classified as having severe to profound learning disability, and among those in residential care. For both waves, Down’s syndrome and cerebral palsy were associated with increased hazards for both events; Down’s syndrome to a greater extent. Hazard ratios for non-covid deaths followed similar patterns with weaker associations. Similar patterns of increased relative risk were seen for children, but covid-19 related deaths and hospital admissions were rare, reflecting low event rates among children. Conclusions People with learning disability have markedly increased risks of hospital admission and death from covid-19, over and above the risks observed for non-covid causes of death. Prompt access to covid-19 testing and healthcare is warranted for this vulnerable group, and prioritisation for covid-19 vaccination and other targeted preventive measures should be considered.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Health inequalities and people with learning disabilities in the UK

                Bookmark

                Author and article information

                Journal
                Lancet Public Health
                Lancet Public Health
                The Lancet. Public Health
                The Author(s). Published by Elsevier Ltd.
                2468-2667
                16 April 2023
                May 2023
                16 April 2023
                : 8
                : 5
                : e325-e326
                Affiliations
                [a ]International Centre for Evidence in Disability, London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK
                Article
                S2468-2667(23)00077-4
                10.1016/S2468-2667(23)00077-4
                10139008
                332150d2-06ca-4e12-b1bc-101fb41d002e
                © 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license

                Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

                History
                Categories
                Comment

                Comments

                Comment on this article